戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              RACE (Rapid Amplification of cDNA Ends) identified a 1.5
2                                              RACE (rapid amplification of cDNA ends) PCR is useful fo
3                                              RACE analysis extended the sequence and identified this
4                                              RACE and RT-PCR identified a splice variant of FKBP8 lac
5                                              RACE describes all alveoli that visibly change volume wi
6                                              RACE experiments then mapped the 3' terminus of the upst
7                                              RACE is 55-330 times faster and 2-5 times more accurate
8                                              RACE is easy to use, as it requires adjustment of only t
9                                              RACE mapping revealed that lpiA/acvB were co-transcribed
10                                              RACE processed these terabyte-sized datasets on a single
11                                              RACE was used to identify one major and two minor transc
12                                           3' RACE provided evidence for variability in the 3' UTR due
13             Real-time PCR and 5' RACE and 3' RACE experiments revealed that this locus encodes two tr
14 for the QQS mRNA was identified by 5' and 3' RACE experiments.
15  were obtained by assembling their 5' and 3' RACE polymerase chain reaction products.
16 cloned from nodule mRNA by the RT-PCR and 3' RACE procedures.
17 hain reaction (RT-PCR) followed by 5' and 3' RACE showed that Sh-NOS is a protein of 1,517 amino acid
18 lable immunoglobulin sequences and 5' and 3' RACE to clone and sequence heavy and light chain immunog
19 some 2 were designed, and, through 5' and 3' RACE, clones from 506 genes were sequenced and cDNA sequ
20 nce, reverse transcription-PCR and 5' and 3' RACE.
21 bout 6 kb through conventional RT-PCR and 3' RACE.
22 gene structures were delineated by 5' and 3' RACE.
23 and polyadenylation sites were defined by 3' RACE.
24                                        In 3' RACE, the poly(A) tail functions as a non-specific tag a
25 o nt 7299 or 7307, respectively, by using 3' RACE.
26   Examination of mGL50 cDNA transcripts by 3'RACE revealed an alternatively spliced form, mGL50-B, th
27                                      Using 3'RACE, we confirmed expression of two distinct forms of t
28                         In addition, using 3'RACE, we identified three previously unknown mGlu1 recep
29                                    5'-and 3'-RACE experiments have subsequently identified a 900-bp c
30                                   5'- and 3'-RACE experiments identified a total of 11 R. reniformis
31 T47D breast carcinoma cells by RT-PCR and 3'-RACE PCR and identified a novel extended form of QSOX1 t
32 e use of these conditions yielded 5'- and 3'-RACE products that were approximately 80% GC over 213 an
33  108-158 nt) through genomic analysis and 3'-RACE technique, which was confirmed by RNA blot analysis
34  As an initial step, we performed 5'- and 3'-RACE with SULT1C1 cDNA.
35 ed and verified using RPE/choroid 5'- and 3'-RACE.
36 uence of MIH, in conjunction with 5'- and 3'-RACE.
37  RNA-sequencing data, followed by 5'- and 3'-RACE.
38 ctive polyadenylation sites identified by 3'-RACE are conserved in human, mouse, and chicken SCN8A.
39  from the one for UT-A2 and identified by 3'-RACE new transcripts of UT-A1, UT-A2, and UT-A3, charact
40 5'-methylguanosine-capped RNA followed by 3'-RACE sequencing.
41  amplification of complementary DNA ends (3'-RACE) polymerase chain reaction, we identified a chimeri
42                             We used 5'-or 3'-RACE, GenomeWalking, reverse transcriptase polymerase ch
43                                Subsequent 3'-RACE, 5'-RACE and high fidelity PCR were then used to pr
44 d RNA-Seq procedures, as well as a 1200 bp 5 RACE product coupled with PACBio sequencing that can ide
45                                     Using 5"-RACE we have identified two novel transcripts of utrophi
46                                           5' RACE analysis revealed the presence of a previously unde
47                                           5' RACE analysis revealed the presence of the transcription
48                                           5' RACE analysis was performed to determine the functional
49                                           5' RACE analysis, promoter-reporter assays, and semiquantit
50                                           5' RACE carried out with CWR22Rv1 and HepG2 cells detected
51                                           5' RACE indicates a transcription start site for HYDIN2 out
52                                           5' RACE studies localized the initiation sites to a <100 bp
53 l clones in mediating tumor regression, a 5' RACE technique was used to determine the distribution of
54                         Real-time PCR and 5' RACE and 3' RACE experiments revealed that this locus en
55 validation using RNA cleavage assays, and 5' RACE identified the prooncogenic basic helix-loop-helix
56  obtained by further rounds of RT-PCR and 5' RACE procedures.
57  that gene was then cloned by both 3' and 5' RACE.
58 tained by exon amplification, RT-PCR, and 5' RACE.
59 ' end of the K12 transcript was mapped by 5' RACE (rapid amplification of cDNA ends) and S1 nuclease
60 ranscription start site was identified by 5' RACE (rapid amplification of complementary DNA ends).
61 criptional start sites were determined by 5' RACE analysis.
62 y and late transcripts were identified by 5' RACE and primer walking techniques.
63 ha were mapped within the third intron by 5' RACE and S1 nuclease protection.
64 transcript initiation sites identified by 5' RACE is located 159 nucleotides upstream of the putative
65 onic promoter of miR-9-5 was validated by 5' RACE PCR.
66 ptional initiation site was identified by 5' RACE techniques using total RNA from NIH 3T3 cells.
67 This was followed by sequencing of cloned 5' RACE products and of products re-amplified from excised
68                               We employed 5' RACE to isolate the 5' end of the fusion transcript and
69 ed by rapid amplification of 5' cDNA end (5' RACE), RT-PCR analysis and genome sequence analyses.
70 r to rapid amplification of 5' cDNA ends (5' RACE) for HIV-1 RNA and quantitative reverse transcripta
71  and 5' rapid amplification of cDNA ends (5' RACE) to be located 25 nt upstream of the ATG in exon 1.
72  and rapid amplification of 5' cDNA ends (5' RACE), we have cloned three previously unrecognized endo
73                  The classical scheme for 5' RACE described here is simple, suffices in many instance
74 led with library screening and a modified 5' RACE-PCR strategy, resulted in the identification and ch
75 ys, and independently with inverse PCR of 5' RACE clones, common mRNA initiation sites were identifie
76                               By means of 5' RACE cloning methodology, a novel putative full-length h
77                   The 3000 BP upstream of 5' RACE product were subcloned into a pGL3 luciferase repor
78                Interestingly, analysis of 5' RACE products for antisense transcripts and the GenBank
79                 The approach was based on 5' RACE with [32P]-labelled primers and separation of produ
80 combination of reverse transcription-PCR, 5' RACE, and genomic library screening was used to clone th
81 genomic structure of BMPR1A, we performed 5' RACE from lymphoblastoid cell lines and normal colon tis
82                              We performed 5' RACE on mRNA isolated from murine chondroprogenitor cell
83 le in mediating tumor regression and that 5' RACE analysis may provide an important tool for the anal
84                                       The 5' RACE analysis of the human testis mRNA revealed the exis
85 f the sequence variation defined from the 5' RACE products.
86  with yeast or human DBR1 enzyme prior to 5' RACE and qRT-PCR.
87 rt sites of 69 rpoH-dependent genes using 5' RACE (5' rapid amplification of cDNA ends), which allowe
88                                     Using 5' RACE (rapid amplification of cDNA ends) analysis, multip
89 rame (ORF) of 3.5 kb was elucidated using 5' RACE and genomic sequence.
90 upstream coding region was obtained using 5' RACE methods.
91 e 5' end of the murine Rad51l2 cDNA using 5' RACE technique as well as by sequencing the genomic regi
92 MS1 proximal promoter, initially by using 5' RACE to map transcription start sites.
93                                     Using 5' RACE we have now identified a novel BCL-X non-coding exo
94                                     Using 5' RACE, two transcription initiation sites were identified
95                                     Using 5' RACE, we have isolated four additional exons of the mu o
96                                     Using 5' RACE, we identified three promoters, designated A, B and
97                                     Using 5' RACE, we identified three transcription start sites and
98 rt sites in human MTHFR were mapped using 5' RACE.
99                                          5' -RACE and primer extension identified a long 5' -untransl
100                                            5'RACE followed by functional promoter analysis in multipl
101 cer-testis Ag NY-ESO-1 were cloned using a 5'RACE method from RNA isolated from a CTL generated by in
102                          Bioinformatic and 5'RACE (rapid amplification of cDNA ends) analyses of the
103                                 RT-PCR and 5'RACE experiments confirm the presence of four additional
104                  The results of RT-PCR and 5'RACE suggest that only PRB is inactivated, although PRA
105  results obtained using global RNA-Seq and 5'RACE.
106 H1 and vnfH transcriptional start sites by 5'RACE (5' rapid amplification of cDNA ends) revealed that
107 DNA sequence analysis of cDNA generated by 5'RACE from CSF1R coding sequences identified a novel fusi
108 ' rapid amplification of cDNA ends method (5'RACE), and immunohistochemical staining.
109   Rapid amplification of 5'-cDNA ends-PCR (5'RACE-PCR) revealed at least three novel forms of the unt
110 o alternative promoter was observed by RLM-5'RACE PCR and reverse transcriptase PCR analyses during e
111  amplification of 5' cDNA ends by PCR (RLM-5'RACE PCR) analysis of C. cellulovorans RNA identified a
112     Additionally, sequence analysis of the 5'RACE-PCR products revealed multiple transcriptional star
113                                      Using 5'RACE, we demonstrate that Giardia promoters are a source
114  in vitro DNA-binding assays combined with 5'RACE, that BrlR binds to its own promoter, likely via a
115                                           5'-RACE (rapid amplification of cDNA ends) data indicate th
116                                           5'-RACE analysis defined transcript start sites for sbi, ef
117                                           5'-RACE analysis of mouse embryo cDNA targeting five candid
118                                           5'-RACE identified p53 mRNA transcribed from a novel start
119                                           5'-RACE mapped the transcription start site for one of the
120 d several alternative splice sites with a 5'-RACE approach.
121 rmed by RNA-Sequencing, and extended by a 5'-RACE assay and Northern blotting, showing that meiotic c
122                                         A 5'-RACE study determined the transcriptional start site of
123                  This prompted additional 5'-RACE experiments that established a second, TATA box-con
124                     Database analysis and 5'-RACE (rapid amplification of cDNA ends) identified a 419
125                                RT-PCR and 5'-RACE analysis revealed that cdr and bb0729 are co-transc
126 ive RT-PCR and used for Northern blot and 5'-RACE analysis.
127 scripts produced from the dnaK operon and 5'-RACE mapped 5' termini of multiple dnaK transcripts with
128                                RT-PCR and 5'-RACE mapping showed that the 5' UTR has a length of 1.94
129 ere cloned from a skin library by 3'- and 5'-RACE reactions.
130                cDNA library screening and 5'-RACE revealed that the major transcript encoded an open-
131 ning strategy (RT-PCR followed by 3'- and 5'-RACE) to clone from Y-organs of the blue crab (Callinect
132 enes by using a combination of RT-PCR and 5'-RACE.
133  cleavage of a subset of these targets by 5'-RACE analysis.
134 anscriptional start of human CRLR cDNA by 5'-RACE and cloned the proximal 5'-flanking region of the g
135 by comparing the repertoires generated by 5'-RACE PCR and multiplex PCR.
136 tes of all three genes were determined by 5'-RACE revealing large leader sequences for each transcrip
137                    Transcript analysis by 5'-RACE suggested a mechanism for allelic differences: an o
138 d associated promoter (P1), was mapped by 5'-RACE to a region 19 kb upstream of the ZFP106 translatio
139 l cDNA amplification strategy followed by 5'-RACE, we have identified several gene products whose exp
140 nt upstream of the ATG initiation site by 5'-RACE.
141      Rapid amplification of 5'-cDNA ends (5'-RACE) analysis demonstrated exclusive use of the CBS -1b
142      5'-rapid amplification of cDNA ends (5'-RACE) and computational analyses were used to identify c
143      Rapid amplification of 5'-cDNA ends (5'-RACE) and reverse transcription-PCR assays identified sh
144      Rapid amplification of cDNA 5'-ends (5'-RACE) identified additional upstream exon 1 sequence tha
145  and 5'-rapid amplification of cDNA ends (5'-RACE) revealed five major ADAR1 transcriptional start si
146         Rapid amplification of cDNA ends (5'-RACE) was used to isolate the CDT6 promoter from an adap
147 cs analysis, rapid analysis of cDNA ends (5'-RACE), and reverse transcription coupled with qPCR using
148 ing 5' random amplification of cDNA ends (5'-RACE), and the binding sites for purified HlyU were disc
149 ing rapid amplification of the cDNA ends (5'-RACE), we identified one transcription start site (TSS).
150 entary deoxyribonucleic acid (cDNA) ends (5'-RACE).
151 ngest 5'-untranslated region derived from 5'-RACE and apparently generated by the distal promoter has
152   Here we report the isolation by genomic 5'-RACE PCR and in vitro analysis of the mouse PIASgamma pr
153 oth endothelial cells and liver; however, 5'-RACE analysis (rapid amplification of cDNA ends) identif
154          We obtained evidence by modified 5'-RACE for a MYB mRNA cleavage product guided by miR828 in
155 RNA, whose cleavage was shown by modified 5'-RACE.
156 question, we conducted deep sequencing of 5'-RACE products of the Igh repertoire in pro-B cells, ampl
157 he neuronal channel SCN8A, we carried out 5'-RACE (rapid amplification of cDNA ends) with RNA from hu
158                         We also performed 5'-RACE experiments on 62 novel regions, and 76% of the reg
159                       Subsequent 3'-RACE, 5'-RACE and high fidelity PCR were then used to produce a f
160 eight were further confirmed with the RLM 5'-RACE experiments.
161 uently full-length cDNA was cloned by the 5'-RACE (rapid amplification of cDNA ends) technique and se
162                                       The 5'-RACE analysis of RARbeta2 mRNA in these cells demonstrat
163 , both the RNase protection assay and the 5'-RACE assay detected endogenous pim-1 transcripts with sh
164 d" antibody repertoires by sequencing the 5'-RACE PCR products of B-cell transcripts from IAVI donor
165                                  By using 5'-RACE, alignment of EST sequences, and a luciferase-repor
166 o be mediated by an RNAi mechanism, using 5'-RACE.
167 s in vitro and murine enterocytes in vivo.5'-RACE identified two novel exons, 1A and 1B, which encode
168                     Using Primer walking, 5'-RACE PCR and in silico analyses, we characterized nine J
169                                   Additional RACE and Northern analysis revealed that at least five d
170 end-polymerase chain reaction amplification (RACE-PCR).
171  Reverse transcription-PCR amplification and RACE were used to acquire the former menthone:(-)-(3R)-m
172  Reverse transcription-PCR amplification and RACE were used to acquire the remaining 5'-sequence from
173  which 6 were confirmed by northern blot and RACE.
174         This work demonstrates Raman-DIP and RACE are effective culture-independent approach for rapi
175 was obtained and verified through RT-PCR and RACE (rapid amplification of cDNA ends).
176         The gene was amplified by RT-PCR and RACE of the poly(A)+RNA isolated from the mouse melanoma
177 s of this novel gene using interexon PCR and RACE technologies.
178 ction of oligonucleotide primers for PCR and RACE-derived cDNAs from which the complete sequence of f
179  novel sequences by using degenerate PCR and RACE.
180                                     We apply RACE-Seq to 398 human lncRNA genes in seven tissues, lea
181 orporating other transcriptomic data such as RACE, CAGE, and EST into its model to further increase i
182 yosuroides hydrolase (Amgdsh1) was cloned by RACE-PCR and expressed in the yeast Pichia pastoris as a
183 sequence of the DCAL-1 gene was confirmed by RACE-PCR; however, based on sequence alignment with geno
184    All corresponding cDNAs were confirmed by RACE.
185 using bioinformatic predictions, followed by RACE, RT-PCR, and sequencing.
186             We then cloned the novel gene by RACE-PCR, and analysis of the deduced cDNA sequence foun
187 ons of the mouse OR genes were identified by RACE-PCR.
188 ouse ovarian adapter-ligated cDNA library by RACE-PCR, and a unique 2043-bp open reading frame was de
189 s or siRNA and analyzed cleavage products by RACE.
190 ate Control Versus Electrical Cardioversion (RACE) trials that anticoagulation should not be disconti
191                                      Current RACE methods often produce a high background of nonspeci
192 e extremely GC-rich sequences, using current RACE methods.
193 nfarction in Carolina Emergency Departments (RACE) project, transported via emergency medical service
194                             Here we describe RACE-Seq, an experimental workflow designed to address t
195                               Many different RACE methods have been developed to meet various require
196               Raman activated cell ejection (RACE) was applied to isolate single AMR bacteria for the
197        5' Random amplification of cDNA ends (RACE) analyses identified two distinct promoters, p1 and
198         5' rapid amplification of cDNA ends (RACE) analyses of RNAs prepared from G50DblKo and wild-t
199         3'-Rapid amplification of cDNA ends (RACE) analyses of the terminated RNA products allowed pr
200         5' rapid amplification of cDNA ends (RACE) and deletion analysis were used to identify the di
201 erns using rapid amplification of cDNA ends (RACE) and full-length cDNA sequencing, revealed four ind
202 such as 5'-Rapid Amplification of cDNA Ends (RACE) and inverse polymerase chain reaction (PCR).
203 ations, 3' rapid amplification of cDNA ends (RACE) and polymerase chain reactions (PCR) were performe
204 luding the rapid amplification of cDNA ends (RACE) and tiling array technologies that was used to fur
205 ted by the rapid amplification of cDNA ends (RACE) approach.
206  5' and 3' rapid amplification of cDNA ends (RACE) experiments and findings of novel splicing events
207 ction, and rapid amplification of cDNA ends (RACE) experiments indicate the presence of multiple tran
208 m adapting rapid amplification of cDNA ends (RACE) for large-scale structural transcript annotation.
209 ies and by rapid amplification of cDNA ends (RACE) from liver, spleen and lung RNA.
210 sis and 3' rapid amplification of cDNA ends (RACE) in placenta confirmed the existence of distal intr
211            Rapid amplification of cDNA ends (RACE) is widely used to determine the 5'- and 3'-termina
212 mRNA using rapid amplification of cDNA ends (RACE) PCR as long as part of the mRNA sequence is known;
213 sults from rapid amplification of cDNA ends (RACE) PCR suggest that there are multiple transcriptiona
214 t using 5' rapid amplification of cDNA ends (RACE) PCR.
215         3' rapid amplification of cDNA ends (RACE) polymerase chain reaction (PCR) from bone marrow m
216        The rapid amplification of cDNA ends (RACE) procedure is a widely used PCR-based method to clo
217 5'- and 3'-rapid amplification of cDNA ends (RACE) product and assembling the sequences, we generated
218 5'- and 3'-Rapid Amplification of cDNA Ends (RACE) revealed IGH/CHST11 as well as CHST11/IGH fusion R
219  have used rapid amplification of cDNA ends (RACE) to identify multiple transcription initiation and
220            Rapid amplification of cDNA ends (RACE) was performed on RNA isolated from human RPE cells
221            Rapid amplification of cDNA ends (RACE) was used to obtain potentially full-length transcr
222  method of rapid amplification of cDNA ends (RACE) was used to obtain their cDNA sequences from 11 cD
223 ned using random amplification of cDNA ends (RACE), and promoter regions were compared with orthologu
224 encing, 3' rapid amplification of cDNA ends (RACE), and tiled microarray analyses.
225  (RT-PCR), rapid amplification of cDNA ends (RACE), and transient expression of minigene constructs.
226 ed with 5' rapid amplification of cDNA ends (RACE), in vitro transcription assays, real-time quantita
227 etected by rapid amplification of cDNA ends (RACE), primer extension, and ribonuclease protection ass
228      Using rapid amplification of cDNA ends (RACE), reverse-transcription polymerase chain reaction (
229 , using 5' rapid amplification of cDNA ends (RACE), two transcriptional start sites (TSSs) and two pu
230   Using 3' rapid amplification of cDNA ends (RACE), we mapped the 3' end of the N and NSs mRNAs, show
231 y using 5' rapid amplification of cDNA ends (RACE), we mapped two HPV18 transcription start sites (TS
232            Rapid amplification of cDNA ends (RACE)-PCR extension of expressed sequence-tag sequences
233 solated by rapid amplification of cDNA ends (RACE).
234 loning and rapid amplification of cDNA ends (RACE).
235 scripts by rapid amplification of cDNA ends (RACE).
236 T-PCR) and rapid amplification of cDNA ends (RACE).
237 y by using rapid amplification of cDNA ends (RACE).
238 ermined by rapid amplification of cDNA ends (RACE).
239 ssed by 5' Rapid Amplification of cDNA Ends (RACE).
240 pid amplification of complementary DNA ends (RACE), chemical inhibition experiments, and genetic disr
241 pid amplification of complementary DNA ends (RACE), two transcriptional start sites were identified.
242 repetitive alveolar collapse and expansion" (RACE).
243 the Real-time Accurate Cell-shape Extractor (RACE), a high-throughput image analysis framework for au
244                 We describe here an improved RACE procedure using circular cDNA templates and demonst
245                 Thus, the term "collapse" in RACE refers to a visibly obvious collapse of the alveolu
246  by the development of alveolar instability (RACE) and the increase in alveolar size at peak inspirat
247                    We furthermore integrated RACE with our framework for automated cell lineaging and
248             We have used RNA ligase mediated RACE and in silico analyses to locate two sets of transc
249 tokine termed IL-17D was cloned using nested RACE PCR.
250 kine, termed IL-17F, was cloned using nested RACE PCR.
251                                         'New RACE' (rapid amplification of cDNA ends) PCR is a method
252                     Thus, we developed a new RACE method that can be used for this purpose.
253                                Although 'new RACE' can also be used to amplify 3' ends, only the prot
254                                      In 'new RACE', an anchor is ligated to the 5' end of the mRNA be
255  of effector action, the requirement for NON-RACE-SPECIFIC DISEASE RESISTANCE1 (NDR1) is shared.
256       Arabidopsis (Arabidopsis thaliana) NON-RACE-SPECIFIC DISEASE RESISTANCE1 (NDR1), a plasma membr
257                                  We obtained RACE data for approximately two-thirds of the examined t
258                         Sequence analysis of RACE products showed that the truncation is due to a sin
259             We demonstrate the generality of RACE by extracting cell-shape information from entire Dr
260                                  By means of RACE PCR, three full-length cDNAs not reported previousl
261 l workflow designed to address this based on RACE (rapid amplification of cDNA ends) and long-read RN
262 ing 5' rapid amplification of cDNA ends-PCR (RACE-PCR), and strong sigma(54) and sigma(70) consensus
263 by PCR-rapid amplification of cDNA ends (PCR-RACE).
264 diated Rapid Amplification of cDNA Ends (PPM-RACE).
265 tion of cDNA ends polymerase chain reaction (RACE PCR).
266 ementary DNA ends-polymerase chain reaction (RACE-PCR) on patient RNA, rabaptin-5 was identified as a
267                               Gene reporter, RACE, and chemical inhibitor studies demonstrated that t
268  from Hydra vulgaris using 3'- and 5'- (RLM) RACE approaches.
269                      Experiments using 5'RLM-RACE demonstrated that the genes EpSPL1, 2, 3, 4, 7, 9,
270 transcriptome profiling combined with 5'-RLM-RACE analysis in transgenic plants confirmed that amiRNA
271 In the current work, we have utilized 5'-RLM-RACE to examine the influence of CGG repeat number on th
272 diated rapid amplification of cDNA ends (RLM-RACE) and RT-PCR to identify four transcription start si
273 diated rapid amplification of cDNA ends (RLM-RACE) between -61 and -32 bp from the translation initia
274 diated rapid amplification of cDNA ends (RLM-RACE) PCR analysis indicated that the single transcripti
275 diated rapid amplification of cDNA ends (RLM-RACE) reads, and 50,000 cap-trapped expressed sequence t
276 their 5' and 3' UTR were amplified using RLM-RACE.
277 e corrected proactively with our large-scale RACE platform.
278 otting, reverse transcription-PCR, and SMART-RACE analyses suggest that the dlt transcript begins 250
279 med systematic series of pseudogene-specific RACE analyses.
280 lve altered alveolar mechanics, specifically RACE and alveolar overdistension.
281 sted gene-specific primer and the 3' or 5' T-RACE primer results in specific amplification of cDNA en
282                        Overall, we show that RACE-Seq is an effective tool to annotate an organism's
283                                          The RACE amplification technology was used on a novel CYP3A-
284                                          The RACE II (Rate Control Efficacy in Permanent Atrial Fibri
285                         The sequences of the RACE sorted cells indicate that they were potential huma
286                 In addition, high-throughput RACE successfully extended the 5' and/or 3' ends of >60%
287 sing this targeted approach, high-throughput RACE, we revealed numerous transcripts including many un
288  associated with the 5'-ends of at least two RACE products.
289                                        Using RACE PCR, reverse transcription-PCR (RT-PCR) and RNA-seq
290                                        Using RACE procedures, we cloned and sequenced the complete 4.
291                                        Using RACE, we automatically reconstructed cellular-resolution
292 sis of the 5'- and 3'-ends of the mRNA using RACE analysis determined that the ADH4 mRNA in C57BL/6 m
293 th cDNAs of each product were obtained using RACE-PCR.
294 nfirmed its 3' end nucleotide sequence using RACE-PCR.
295 of supporting evidence and tested them using RACE-PCR.
296 se results show that direct validation using RACE-PCR can be an important component of genome-wide va
297  simple, suffices in many instances in which RACE is needed and can be performed in 1-3 days.
298 thology, whereas lung tissue from areas with RACE mechanics demonstrated alveolar collapse, atelectas
299        RT-PCR sequencing in combination with RACE on ab initio gene predictions could be used to defi
300 ing strand-specific RT-PCR complemented with RACE and FISH.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top